Pharmagreen Biotech Inc. Stock Analysis PHBI
Pharmagreen Biotech, Inc. is a biotech sciences company with specialized products and services in the booming cannabis industry. The firm is engaged in developing its line of nutraceutical products, which is a blend of therapeutic plants and mushrooms. Utilizing the Company's expertise in plant genetics, its transgenic program uses the technology available to research and create nutraceuticals, and daily supplements with the potential to improve lives and address a variety of ailing conditions. The MaxGenomic Supplement is a proprietary blend that consists of nine medicinal mushrooms and six medical plants to help support the human mind and body. Its nutraceutical product, MaxGenomic Supplement, comes in a bottle of 60 enteric capsules. Its other nutraceutical products are in various development stages. Its products are marketed and are available through online stores, such as Amazon and Shopify.
Read More Pharmagreen Biotech Inc (PHBI) Chart
Key Statistics of Pharmagreen Biotech Inc (PHBI)
Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.
Today's Range
Today's Open
$0.00Volume
158.82KP/E Ratio (TTM)
-52 Week Range
Market Cap
1.19MAvg. Volume
2.23MDividend Yield
-Financial Metrics & Statements of Pharmagreen Biotech Inc (PHBI)
FAQ's for Pharmagreen Biotech Inc (PHBI)
- According to Musaffa’s Shariah screening methodology, Pharmagreen Biotech Inc (PHBI) is currently classified as NOT COVERED as of May 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.